Hanmi Reports Second Quarter 2020 Results
2020 Second Quarter Highlights: Net income of $9.2 million, or $0.30 per diluted share, up from net income of $2.4 […]
Aquestive Therapeutics to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference
WARREN, N.J., July 28, 2020 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company focused on developing and commercializing […]
AMD Reports Second Quarter 2020 Financial Results
SANTA CLARA, Calif., July 28, 2020 (GLOBE NEWSWIRE) — AMD (NASDAQ:AMD) today announced revenue for the second quarter of 2020 […]
Western New England Bancorp, Inc. Reports Results for Three and Six Months Ended June 30, 2020 and Declares Quarterly Cash Dividend
WESTFIELD, Mass., July 28, 2020 (GLOBE NEWSWIRE) — Western New England Bancorp, Inc. (the “Company” or “WNEB”) (NasdaqGS: WNEB), the […]
La Jolla Pharmaceutical Company Announces the Closing of Acquisition of Tetraphase Pharmaceuticals, Inc.
SAN DIEGO, California and WATERTOWN, Massachusetts, July 28, 2020 (GLOBE NEWSWIRE) — La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is […]
Palomar Holdings, Inc. Confirms AM Best Assigns Credit Ratings to Palomar Excess and Surplus Insurance Company
LA JOLLA, Calif., July 28, 2020 (GLOBE NEWSWIRE) — Palomar Holdings, Inc. (NASDAQ: PLMR) (the “Company”) today confirmed that AM […]
Sunesis Announces Proposed Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., July 28, 2020 (GLOBE NEWSWIRE) — Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it intends […]
Garrison Capital Inc. Schedules Earnings Release for the Second Quarter Ended June 30, 2020
NEW YORK, July 28, 2020 (GLOBE NEWSWIRE) — Garrison Capital Inc., a business development company (the “Company”) (Nasdaq: GARS), announced […]
HTG Launches New HTG EdgeSeq Pan B-Cell Lymphoma Panel
TUCSON, Ariz., July 28, 2020 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose […]
Annexon Announces Closing of Initial Public Offering
SOUTH SAN FRANCISCO, Calif., July 28, 2020 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a […]
